Joining VeloClub not only supports the work we do, there are some fantastic benefits:
by Shane Stokes
December 14, 2017
Chris Froome urine test reveals twice the legal amount of Salbutamol; Nibali on Froome salbutamol case: No one can give me back the thrill of winning the Vuelta; Vuelta a España expresses ‘extreme caution’ about Froome situation; The Secret Pro: My thoughts on Froome’s positive and the bikes we ride; Tucker analyses Froome case; INRNG on what comes next for Froome; Podcast: Chris Froome’s positive; Ewan confirmed for Tour de France debut in 2018; Stig Broeckx pushes through rehab; Aqua Blue reveals 2018 kit
Chris Froome (Team Sky) has returned an “adverse analytical finding” for Salbutamol in a urine sample taken at this year’s Vuelta a Espana. The sample, which was taken after stage 18 of the Vuelta — a race Froome went on to win — contained 2,000 nanograms per millilitre (ng/ml) of Salbutamol, twice the 1,000 ng/ml permitted by the World Anti Doping Agency (WADA).
An analysis of Froome’s B sample confirmed the results of the A sample and, according to the UCI, “proceedings are being conducted in line with the UCI Anti-Doping Rules”.
Salbutamol is a common medication used to relieve the symptoms of asthma and is permitted for use without a therapeutic use exemption, up to a threshold. Froome reportedly experienced “acute asthma symptoms” during the Vuelta a Espana, requiring further medication.
“It is well known that I have asthma and I know exactly what the rules are,” Froome said via a Team Sky press release. “I use an inhaler to manage my symptoms (always within the permissible limits) and I know for sure that I will be tested every day I wear the race leader’s jersey.
“My asthma got worse at the Vuelta so I followed the team doctor’s advice to increase my Salbutamol dosage. As always, I took the greatest care to ensure that I did not use more than the permissible dose.”
Click through to read the full story on CyclingTips.